Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Nutr J. 2011 Sep 30;10:102. doi: 10.1186/1475-2891-10-102.
Evidence suggests that folate deficiency may be causatively linked to depressive symptoms. However, little is known on the status of use of folic acid and vitamin supplements among people with mental disorders. This study examined the prevalence and the likelihood of use of folic acid or vitamin supplements among adults with depression and anxiety in comparison to those without these conditions.
Using data from 46, 119 participants (aged ≥ 18 years) in the 2006 Behavioral Risk Factor Surveillance System survey, we estimated the adjusted prevalence and odds ratios with 95% confidence intervals for taking folic acid and vitamin supplements among those with ever diagnosed depression (n = 8, 019), ever diagnosed anxiety (n = 5, 546) or elevated depressive symptoms (n = 3, 978, defined as having a depression severity score of ≥ 10 on the Patient Health Questionnaire-8 diagnostic algorithm).
Overall, women were more likely than men to take folic acid supplements 1-4 times/day (50.2% versus 38.7%, P < 0.001) and vitamin supplements (62.5% versus 49.8%, P < 0.001). After multivariate adjustment, men with ever diagnosed depression or anxiety were 42% and 83%, respectively, more likely to take folic acid supplements < 1 time/day; 44% and 39%, respectively, more likely to take folic acid supplements 1-4 times/day; and 40% and 46%, respectively, more likely to take vitamin supplements compared to men without these conditions (P < 0.05 for all comparisons). Women with ever diagnosed depression were 13% more likely to take folic acid supplements 1-4 times/day and 15% more likely to take vitamin supplements than women without this condition (P < 0.05 for both comparisons). Use of folic acid and vitamin supplements did not differ significantly by elevated depressive symptoms in either sex.
The prevalence and the likelihood of taking folic acid and vitamin supplements varied substantially by a history of diagnosed depression among both men and women and by a history of diagnosed anxiety among men, but not by presence of elevated depressive symptoms in either sex.
有证据表明,叶酸缺乏可能与抑郁症状有因果关系。然而,人们对精神障碍患者叶酸和维生素补充剂的使用情况知之甚少。本研究比较了患有抑郁和焦虑症的成年人与无这些疾病的成年人使用叶酸或维生素补充剂的情况。
使用来自 2006 年行为风险因素监测系统调查的 46119 名(年龄≥18 岁)参与者的数据,我们估计了曾被诊断患有抑郁症(n=8019)、曾被诊断患有焦虑症(n=5546)或出现抑郁症状升高(n=3978,定义为使用患者健康问卷-8 诊断算法时的抑郁严重程度评分为≥10)的成年人服用叶酸和维生素补充剂的调整后患病率和比值比(95%置信区间)。
总体而言,女性比男性更有可能每天服用 1-4 次叶酸补充剂(50.2%对 38.7%,P<0.001)和维生素补充剂(62.5%对 49.8%,P<0.001)。经过多变量调整后,曾被诊断患有抑郁症或焦虑症的男性每天服用叶酸补充剂<1 次的可能性分别增加了 42%和 83%;每天服用 1-4 次叶酸补充剂的可能性分别增加了 44%和 39%;每天服用维生素补充剂的可能性分别增加了 40%和 46%,与无这些疾病的男性相比(所有比较的 P<0.05)。曾被诊断患有抑郁症的女性每天服用 1-4 次叶酸补充剂的可能性增加了 13%,服用维生素补充剂的可能性增加了 15%,与无此疾病的女性相比(两种比较均 P<0.05)。在男性和女性中,服用叶酸和维生素补充剂的情况与抑郁症状升高的程度没有显著差异。
在男性中,曾被诊断患有抑郁症和曾被诊断患有焦虑症的男性以及女性中,叶酸和维生素补充剂的使用情况和使用可能性存在显著差异,而在男性和女性中,抑郁症状升高与服用叶酸和维生素补充剂的情况无显著相关性。